Cargando…
Local Drug Delivery Strategies for Glioblastoma Treatment
Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various dru...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353160/ https://www.ncbi.nlm.nih.gov/pubmed/35929112 http://dx.doi.org/10.14791/btrt.2022.0017 |
_version_ | 1784762813888069632 |
---|---|
author | Cha, Gi Doo Jung, Sonwoo Choi, Seung Hong Kim, Dae-Hyeong |
author_facet | Cha, Gi Doo Jung, Sonwoo Choi, Seung Hong Kim, Dae-Hyeong |
author_sort | Cha, Gi Doo |
collection | PubMed |
description | Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. Therefore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of chemotherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM. |
format | Online Article Text |
id | pubmed-9353160 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-93531602022-08-12 Local Drug Delivery Strategies for Glioblastoma Treatment Cha, Gi Doo Jung, Sonwoo Choi, Seung Hong Kim, Dae-Hyeong Brain Tumor Res Treat Review Article Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. Therefore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of chemotherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM. The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology 2022-07 2022-07-28 /pmc/articles/PMC9353160/ /pubmed/35929112 http://dx.doi.org/10.14791/btrt.2022.0017 Text en Copyright © 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Cha, Gi Doo Jung, Sonwoo Choi, Seung Hong Kim, Dae-Hyeong Local Drug Delivery Strategies for Glioblastoma Treatment |
title | Local Drug Delivery Strategies for Glioblastoma Treatment |
title_full | Local Drug Delivery Strategies for Glioblastoma Treatment |
title_fullStr | Local Drug Delivery Strategies for Glioblastoma Treatment |
title_full_unstemmed | Local Drug Delivery Strategies for Glioblastoma Treatment |
title_short | Local Drug Delivery Strategies for Glioblastoma Treatment |
title_sort | local drug delivery strategies for glioblastoma treatment |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353160/ https://www.ncbi.nlm.nih.gov/pubmed/35929112 http://dx.doi.org/10.14791/btrt.2022.0017 |
work_keys_str_mv | AT chagidoo localdrugdeliverystrategiesforglioblastomatreatment AT jungsonwoo localdrugdeliverystrategiesforglioblastomatreatment AT choiseunghong localdrugdeliverystrategiesforglioblastomatreatment AT kimdaehyeong localdrugdeliverystrategiesforglioblastomatreatment |